BioIQ, the leader in consumer-friendly health testing products and services, and Alere®, who provides services that include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions to health plans, employers, and government agencies, will work together to supply BioIQ’s home-test kits and online reporting tools as part of Alere’s Personal Health Solutions.
“In today’s increasingly virtual world, more employees are working remotely, either from home or satellite locations,” said Dr. Ron Geraty, CEO of Alere. “By identifying risk factors early, we can in many cases minimize the impact of conditions such as diabetes, heart disease, hypertension and obesity. With this expanded Screening Services offering, Alere will be able to reach both employees and dependents more effectively.”
As part of this workplace-wellness initiative, participants of Alere’s Screening Services Programs will order BioIQ test kits via a secure website, which are then mailed to their homes. Each kit includes instructions for drawing a small blood sample through a simple finger-prick method and mailing it to a certified laboratory for analysis. Measurements include high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglycerides, hemoglobin/A1c, and fasting glucose. A single-sign-on login process will enable Alere participants to seamlessly access BioIQ’s enrollment and lab results pages via secure personal accounts. In addition, the results from the BioIQ tests will be automatically loaded into each participant’s Health & Productivity Assessment and Personal Health Record, which are part of Alere’s Wellness Solutions.
“BioIQ adds to Alere’s current on-site and in-home screening offering, enabling them to screen more people and more effectively identify health risks,” said Justin Bellante, CEO at BioIQ. “Biometric testing leads to more effective interventions, treatment, and follow-up.”
BioIQ is a healthcare information technology company that develops and markets medical diagnostic solutions through corporate, institutional and direct-to-consumer channels. The company’s affordable and innovative home test kits are commonly used to monitor or screen for diabetes, cancer, heart disease, kidney disease, thyroid disorder, osteoporosis, and other chronic health conditions.
Alere is a member of the Inverness Medical Innovations family of companies and represents the union of Alere Medical, ParadigmHealth and Matria® Healthcare. Alere is the Latin verb meaning “to care for” or “to support”. Services include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions and high-risk pregnancy and NICU management. In addition, in-home diagnostics monitoring devices address the need for the daily monitoring of medium- and high-risk patients. Inverness Medical Innovations is a global leader in rapid point-of-care diagnostics, cardiology, oncology, women’s health and health management services. More information can be found about Alere at www.alere.com.
Press Contact: David Baum
BioIQ Press Relations